#
Title
1

Designing a Global Market Access Strategy Built for MFN

2

LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico

3

The Evolving NHS – An ICS Chief Pharmacist’s Perspective

4

First to Market: Unlocking Switzerland’s Pharma Potential

5

Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice

6

Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

7

Transforming Global Market Access: Smarter Resource Management with Local Affiliates

8

Communicating value to US Payers: Insights for Pharma and Medtech

9

Navigating market access: Launch strategies and health economic modelling for medical devices

10

Navigating US payer evidence needs to optimise market access

11

Best practice RWE approaches to support economic modelling for HTA

12

NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

13

De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

14

NHS primary care panel – the GP Contract and Operational Planning Guidance

15

Engage NHS healthcare decision-makers with RWD

16

Market access and reimbursement in Canada – changes at CADTH

17

Rare Disease market access in the MENA and Nordic regions

18

How does funding flow in NHSE Regions?

19

NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

20

De-mystifying health economic model classifications and structures

21

Evidence strategy for Medical Technologies and Diagnostics

22

How to set your Pharma or Medtech product up for success in the US market

23

What's happening with specialised commissioning in the NHS?

24

Integrated care in NHS Wales – what can England learn from its neighbour?

25

Market access in Italy: Reforms at AIFA

26

Unmet need in NHS primary care – How can industry best support PCN leaders?

27

Population health management: a community effort across health and life sciences

28

Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

29

6 areas of UK health policy for Medtech to pay attention to

30

Market access in the German speaking markets

31

The role of nursing in driving digital change in the NHS

32

Market access for digital therapies and digital medicines

33

A global market access journey in cannabinoid pharmaceuticals

34

Primary Care and ICBs – what is the next step in the integration journey?

35

Data-led transformation in the NHS - partnering to optimise patient care

36

Innovating for better health – research, collaboration and innovation in the NHS

37

Healthcare, economics and society – unlocking NHS collaboration

38

Specialised Commissioning in the NHS – What do you need to know now

39

Why are we waiting? - Pressures facing the NHS and how to deliver change

40

Priority setting in primary care - NHS insights

41

Integrated Care Systems go live in the NHS - reflections after 3 weeks

42

Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

43

Transforming systems and care pathways for an integrated NHS

44

Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

45

Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

46

Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

47

The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

48

Optimising the NHS – How will medicines be valued in integrated systems?

49

Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

50

A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)

51

Innovations to address health inequalities in the NHS and how Pharma and Medtech can help

52

The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving

53

Population to person - How will the voice of the individual drive health and care development?

54

Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE

55

Health Economic Modelling for MedTech Innovation - What, Why and How

56

Pharmacy, Medicines, and Specialised Commissioning in the new NHS

57

The White Paper and integrated care in the NHS: What it really means in practice for clinicians, patients and us - with Dr John Ribchester

58

Heads at the heart of the NHS: How mental health is central to everything in the new NHS - with Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust)

59

Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus

60

Is prevention better than the cure? How can the NHS and public health work closer to improve population health?

61

Understanding the tipping point: When elective becomes selective in NHS surgery

62

Leading within an evolving, integrating system: insights from an NHS leader

63

Integrated Care Systems: Separating fact from myth – insights from a system leader

64

The Evolving NHS - Lessons for Pharma and Medtech - NHS insights webinar with David Thorne and Tom Clarke

65

The Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK)

66

The Tech Perspective with Stephen Bourke (Co-Founder of Echo, The Online Pharmacy)

67

Questions Time Special - Views from across the NHS; from costings to strategy to clinical care

68

The Changing Face of Care Delivery Part 2: The Primary Care & Community View with Steve Reed (Head of Community Services, York Teaching Hospitals NHS FT) and Dr John Ribchester (PCN Clinical Director, GP and Chair of Encompass GP Partnership, Whitstable)

69

The Changing Face of Care Delivery Part 1: The System & Hospital View with Berenice Groves (Director of Operations, Blackpool Teaching Hospitals NHS FT) and Tina Teague (COVID Resilience Manager for Devon)

70

Strategic Procurement & Medicines Management with Keith Pearson (Head of Medicines Optimisation, in a CCG) and Simon Wootton (Non Exec Director, in a PCN)

71

Pharmacy & Medicines Management with Samantha O’Connell (GP Clinical Pharmacist) and Johnathan Laird (Prescribing Pharmacist)

72

Finance & Commissioning with Patrick McGinley (Head of Costings and SLR) and Patricia Whelan-Moss (Head of Organisational Development for a CCG)

73

Primary Care & Community Settings with Liz Cross (Advanced Nurse Practitioner) & Dr Su McCole (GP & Area Clinical Director)

74

Introductory overview with PCN lead Hilary Snowdon & Secondary Care Chief Exec Mike Proctor